We are live on ! Find out more
FLAM

First Light Asset Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 114.45%
This Fund
S&P 500
This Quarter Est. Return
+19.44%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$1.11B
AUM Growth
+$33.3M
Cap. Flow
-$6.36M
Cap. Flow %
-0.57%
Top 10 Hldgs %
54.13%
Holding
78
New
4
Increased
24
Reduced
16
Closed
4

Top Buys

Rank Stock Value
1
OFIX icon
Orthofix Medical
OFIX
+$51.9M
2
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$15.1M
3
FNA
Paragon 28, Inc.
FNA
+$14.3M
4
OPRX icon
OptimizeRx
OPRX
+$10.9M
5
PLRX icon
Pliant Therapeutics
PLRX
+$10.5M

Top Sells

Rank Stock Value
1
SPNE
SeaSpine Holdings Corporation Common Stock
SPNE
+$57.4M
2
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$27.9M
3
KRYS icon
Krystal Biotech
KRYS
+$21.8M
4
MODN
MODEL N, INC.
MODN
+$15.6M
5
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$15.6M

Sector Composition

Rank Sector Weight
1 Healthcare 94.41%
2 Communication Services 5.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FMS icon
51
Fresenius Medical Care
FMS
$13.8B
$414K 0.04%
19,490
– –
ELV icon
52
Elevance Health
ELV
$81.5B
$407K 0.04%
886
– –
BAY
53
DELISTED
BAYER AG SPONS ADR
BAY
$406K 0.04%
25,475
– –
ENOV icon
54
Enovis
ENOV
$1.68B
$385K 0.03%
7,203
– –
NVS icon
55
Novartis
NVS
$297B
$379K 0.03%
4,123
– –
QDEL icon
56
QuidelOrtho
QDEL
$1.14B
$379K 0.03%
4,257
– –
GILD icon
57
Gilead Sciences
GILD
$162B
$376K 0.03%
4,526
– –
EXEL icon
58
Exelixis
EXEL
$13.3B
$358K 0.03%
18,445
– –
GSK icon
59
GSK
GSK
$104B
$358K 0.03%
10,058
– –
CNC icon
60
Centene
CNC
$30.7B
$349K 0.03%
5,521
– –
MDT icon
61
Medtronic
MDT
$109B
$338K 0.03%
4,188
– –
JNJ icon
62
Johnson & Johnson
JNJ
$618B
$335K 0.03%
2,161
– –
XRAY icon
63
Dentsply Sirona
XRAY
$2.68B
$323K 0.03%
8,228
– –
VTRS icon
64
Viatris
VTRS
$20.4B
$318K 0.03%
33,010
– –
QGEN icon
65
Qiagen
QGEN
$8.54B
$317K 0.03%
6,518
– –
AVTR icon
66
Avantor
AVTR
$9.32B
$309K 0.03%
14,596
– –
HCA icon
67
HCA Healthcare
HCA
$87.2B
$306K 0.03%
1,160
– –
BIIB icon
68
Biogen
BIIB
$30B
$305K 0.03%
1,096
– –
UTHR icon
69
United Therapeutics
UTHR
$25.8B
$301K 0.03%
1,345
– –
OGN icon
70
Organon & Co
OGN
$3.56B
$299K 0.03%
12,716
– –
RVTY icon
71
Revvity
RVTY
$12.6B
$296K 0.03%
2,223
– –
LH icon
72
Labcorp
LH
$25.4B
$279K 0.03%
1,418
– –
PDCO
73
DELISTED
Patterson Companies, Inc.
PDCO
$248K 0.02%
9,264
– –
SYNH
74
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$204K 0.02%
5,736
– –
BVS icon
75
Bioventus
BVS
$892M
– –
-1,376,536
Closed -$3.59M
1 2
3
4

Similar funds

AIM
Advyzon Investment Management Lisle, Illinois $1.12B AUM 22.08% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
CNC
Canandaigua National Corp Canandaigua, New York $1.12B AUM
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
RIM
Rockbridge Investment Management Syracuse, New York $1.11B AUM 13.62% 1-Year Est. Return
CT
Caldwell Trust Venice, Florida $1.12B AUM 21.31% 1-Year Est. Return
SL
Salomon & Ludwin Richmond, Virginia $1.12B AUM 14.38% 1-Year Est. Return
HH
Hilltop Holdings Dallas, Texas $1.11B AUM 24.7% 1-Year Est. Return

First Light Asset Management's Q1 2023 Portfolio in Review

As of Q1 2023, First Light Asset Management held 78 positions worth $1.11B, up 3.1% from $1.08B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

First Light Asset Management's Q1 2023 filing shows 4 new, 24 increased, 16 reduced and 4 closed positions. Its largest new stake was Orthofix Medical: 2,650,971 shares worth $44.4M. The largest sale was SeaSpine Holdings Corporation Common Stock, an estimated $57.4M.

By sector, the portfolio is most concentrated in Healthcare at 94% of assets, up from 86% a quarter earlier, followed by Communication Services.

  • First Light Asset Management's largest Q1 2023 buy was Orthofix Medical: 2,650,971 shares worth $44.4M.
  • First Light Asset Management added most to Karuna Therapeutics, Inc. Common Stock in Q1 2023, an estimated $15.1M increase.
  • First Light Asset Management's biggest Q1 2023 reduction was Reata Pharmaceuticals, Inc. Class A Common Stock, cutting an estimated $27.9M.
  • First Light Asset Management fully exited SeaSpine Holdings Corporation Common Stock in Q1 2023, selling an estimated $57.4M.
  • First Light Asset Management's ten largest holdings make up 54% of its $1.11B portfolio in Q1 2023.
  • First Light Asset Management opened 4 new positions and closed 4 in Q1 2023.
  • First Light Asset Management's portfolio value rose 3.1% quarter-over-quarter to $1.11B.

Based on First Light Asset Management's 13F filing for Q1 2023, filed 15 May 2023.